Galmed Pharmaceuticals logo

Galmed Pharmaceuticals Share Price Today

(NASDAQ: GLMD)

Galmed Pharmaceuticals share price is $1.84 & ₹160.02 as on 6 Mar 2025, 2.30 'hrs' IST

$1.84

-0.09

(-4.65%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Galmed Pharmaceuticals share price in Dollar and Rupees. Guide to invest in Galmed Pharmaceuticals stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Galmed Pharmaceuticals, along with analyst recommendations, forecasts, and comprehensive financials.

Galmed Pharmaceuticals share price movements

  • Today's Low: $1.80
    Today's High: $1.91

    Day's Volatility :5.76%

  • 52 Weeks Low: $1.84
    52 Weeks High: $23.80

    52 Weeks Volatility :92.27%

Galmed Pharmaceuticals (GLMD) Returns

PeriodGalmed Pharmaceuticals LtdIndex (Russel 2000)
3 Months
-24.61%
0.0%
6 Months
-43.63%
0.0%
1 Year
-56.47%
0.0%
3 Years
-99.2%
-11.6%

Galmed Pharmaceuticals (GLMD) Key Statistics

in dollars & INR

Previous Close
$1.93
Open
$1.89
Today's High
$1.91
Today's Low
$1.8
Market Capitalization
$3.2M
Today's Volume
$8.3K
52 Week High
$23.8
52 Week Low
$1.8
Revenue TTM
$0.0
EBITDA
$-6.7M
Earnings Per Share (EPS)
$69.72
PE Ratio
0.03
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-37.22%

How to invest in Galmed Pharmaceuticals Stock (GLMD) from India?

It is very easy for Indian residents to invest directly in Galmed Pharmaceuticals from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Galmed Pharmaceuticals stock in both Indian Rupees (INR) and US Dollars (USD). Search for Galmed Pharmaceuticals or GLMD on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Galmed Pharmaceuticals or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Galmed Pharmaceuticals shares which would translate to 0.473 fractional shares of Galmed Pharmaceuticals as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Galmed Pharmaceuticals, in just a few clicks!

Returns in Galmed Pharmaceuticals (GLMD) for Indian investors in Rupees

The Galmed Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Galmed Pharmaceuticals investment value today

Current value as on today

₹46,498

Returns

₹53,502

(-53.5%)

Returns from Galmed Pharmaceuticals Stock

₹58,465 (-58.47%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Galmed Pharmaceuticals (GLMD)

-24%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Galmed Pharmaceuticals Stock from India on INDmoney has decreased by -24% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Galmed Pharmaceuticals

  • Schonfeld Strategic Advisors LLC

    1.53%

  • Morgan Stanley - Brokerage Accounts

    0.76%

  • UBS Group AG

    0.41%

Analyst Recommendation on Galmed Pharmaceuticals

Buy

    85%Buy

    14%Hold

    0%Sell

Based on 7 Wall street analysts offering stock ratings for Galmed Pharmaceuticals(by analysts ranked 0 to 5 stars)

Based on 7 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
6
6
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Galmed Pharmaceuticals Stock (GLMD)

What analysts predicted

Upside of 552.17%

Target:

$12.00

Current:

$1.84

Insights on Galmed Pharmaceuticals Stock (Ticker Symbol: GLMD)

  • Price Movement

    In the last 7 days, GLMD stock has moved down by -16.1%
  • GLMD vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 120.5%
  • GLMD vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.7% return, outperforming this stock by 146.9%

Galmed Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Galmed Pharmaceuticals is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Galmed Pharmaceuticals (GLMD) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Galmed Pharmaceuticals Ltd logo
-28.52%
-43.63%
-56.47%
-99.2%
-99.77%
Regeneron Pharmaceuticals, Inc. logo
1.3%
-41.29%
-30.51%
9.2%
42.38%
Beone Medicines Ltd logo
15.19%
34.31%
61.3%
43.16%
68.1%
Vertex Pharmaceuticals Incorporated logo
3.37%
3.77%
18.06%
106.43%
121.36%
Alnylam Pharmaceuticals, Inc. logo
-11.52%
-3.4%
62.32%
49.04%
120.93%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Galmed Pharmaceuticals Ltd logo
0.03
0.03
0.0
0.0
-0.37
-0.22
NA
12.23
Regeneron Pharmaceuticals, Inc. logo
17.85
17.85
1.03
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.33
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Galmed Pharmaceuticals Ltd logo
Buy
$3.2M
-99.77%
0.03
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$74.9B
42.38%
17.85
31.07%
Beone Medicines Ltd logo
NA
$28.5B
68.1%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.1B
121.36%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.5B
120.93%
NA
-12.37%

About Galmed Pharmaceuticals

Galmed Pharmaceuticals Ltd., a biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, a first-in-class synthetic fatty acid-bile acid conjugate molecule which is in Phase III study for oral treatment for non-alcoholic steato-hepatitis (NASH) in patients who are overweight or obese and have prediabetes or type II diabetes mellitus. The company also evaluates Aramchol through ARRIVE Study, a Phase IIa clinical trial with HIV-associated non-alcoholic fatty liver disease and lipodystrophy. In addition, it engages in the development of Amilo-5MER, a 5 amino acid synthetic peptide methionine, threonine, alanine, aspartic acid, and valine. Further, the company develops MyBiotics which is in pre-clinical trials for NASH and fibrosis. It has a license agreement with Samil Pharma. Co., Ltd. for the commercialization of Aramchol in the Republic of Korea; and a collaboration agreement with OnKai for its AI platform. Galmed Pharmaceuticals Ltd. was founded in 2000 and is headquartered in Ramat Gan, Israel.
Organization
Galmed Pharmaceuticals
Employees
3
CEO
Mr. Allen Baharaff
Industry
Health Technology

Management People of Galmed Pharmaceuticals

NameTitle
Mr. Allen Baharaff
Co-Founder, President, CEO & Chairman
Mr. Doron Cohen
Chief Financial Officer
Mr. Guy Nehemya
COO & Data Protection Officer
Mr. Yohai Stenzler CPA
Chief Accounting Officer
Dr. Liat Hayardeny MBA, Ph.D.
Chief Scientific Officer
Dr. Tali Gorfine
Medical Consultant

Important FAQs about investing in GLMD Stock from India :

What is Galmed Pharmaceuticals share price today?

Galmed Pharmaceuticals share price today stands at $1.84, Open: $1.89 ; Previous Close: $1.93 ; High: $1.91 ; Low: $1.80 ; 52 Week High: $23.80 ; 52 Week Low: $1.84.

The stock opens at $1.89, after a previous close of $1.93. The stock reached a daily high of $1.91 and a low of $1.80, with a 52-week high of $23.80 and a 52-week low of $1.84.

Can Indians buy Galmed Pharmaceuticals shares?

Yes, Indians can invest in the Galmed Pharmaceuticals (GLMD) from India.

With INDmoney, you can buy Galmed Pharmaceuticals at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Galmed Pharmaceuticals at zero transaction cost.

How can I buy Galmed Pharmaceuticals shares from India?

It is very easy to buy Galmed Pharmaceuticals from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Galmed Pharmaceuticals (GLMD) be purchased?

Yes, you can buy fractional shares of Galmed Pharmaceuticals with INDmoney app.

What are the documents required to start investing in Galmed Pharmaceuticals stocks?

To start investing in Galmed Pharmaceuticals, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Galmed Pharmaceuticals Stock (GLMD)?

Today’s highest price of Galmed Pharmaceuticals (GLMD) is $1.91.

Today’s lowest price of Galmed Pharmaceuticals (GLMD) is $1.80.

What is today's market capitalisation of Galmed Pharmaceuticals?

Today's market capitalisation of Galmed Pharmaceuticals GLMD is 3.2M

What is the 52 Week High and Low Range of Galmed Pharmaceuticals Stock (GLMD)?

  • 52 Week High

    $23.80

  • 52 Week Low

    $1.84

What are the historical returns of Galmed Pharmaceuticals (GLMD)?

  • 1 Month Returns

    -28.52%

  • 3 Months Returns

    -43.63%

  • 1 Year Returns

    -56.47%

  • 5 Years Returns

    -99.77%

Who is the Chief Executive Officer (CEO) of Galmed Pharmaceuticals ?

Mr. Allen Baharaff is the current Chief Executive Officer (CEO) of Galmed Pharmaceuticals.